September 2, 2020
“Baudax Bio (BXRX) First up we have Baudax Bio, which is a pharmaceutical company focused on developing and commercializing innovative products for acute care settings. With shares changing hands for $2.80, Oppenheimer believes that the share price presents an attractive… Continue Reading…

Recent Comments